Trial Profile
Clinical Trials Insight: 700054120
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 05 Aug 2021
Price :
$35
*
At a glance
- Drugs Tesetaxel (Primary)
- Indications Cancer
- Focus Pharmacokinetics
- Sponsors Genta (CEASED)
- 07 Jun 2010 Recruitment is ongoing.
- 07 Jun 2010 Interim results reported at the ASCO 2010, according to a Genta media release.
- 08 Mar 2010 Start date added as reported by Genta Incorporated.